Education for nurses, patients, family caregivers, and other community support personnel enables the UAHT LVAD program to be successful, whether the devices are placed as a bridge to transplant or ...

With an LVAD heart device, it's a classically complex medical decision: Statistically, you’re likely to do better, but there’s a serious chance you’ll be made seriously worse.

In 2006, Steve Pitkin suffered a serious heart attack while hiking above Salt Lake City with his daughter. The main artery in Pitkin’s heart was completely blocked, leaving 70% of his left ventricle ...

In 2011, The Christ Hospital Heart & Vascular Institute (TCHHVI) launched a left ventricular assist device, or LVAD, program to offer advanced care and support for heart failure patients.

These patients get what’s called an LVAD — a left ventricular assist device — which helps pump their blood, and it can truly be a lifesaver.

End-stage heart failure patients who receive a surgically implanted left ventricular assist device heart pump may also benefit from a single dose of millions of powerful cells injected directly ...

Sue Baker was told that she had two options after her heart started to fail after years of intervention: Enter palliative care, or try an experimental surgery.

In contrast, most end-stage heart failure patients who don't get an LVAD have very little quality of life, and their average one-year survival with the best medical therapy is 30-50 percent.

The group created 3D digital twins of each LVAD patient using detailed imaging of the aorta, nearby blood vessels and the part of the LVAD that attaches to it.

Find out more about life-saving LVAD technology and the medical marvels accomplished with it at NewYork-Presbyterian Hospital.

LVAD therapy is not a panacea and will not be the treatment of choice for all patients in end-stage heart failure.